adi pharma limited
adi pharma limited Company Information
Company Number
09897158
Next Accounts
Aug 2025
Industry
Wholesale of pharmaceutical goods
Retail sale via mail order houses or via Internet
Directors
Shareholders
urvashiben kapadiya
Group Structure
View All
Contact
Registered Address
unit 4 the workshops, greenfield road, bedford, MK45 5BF
Website
adipharma.co.ukadi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £2.2m based on a Turnover of £4.9m and 0.45x industry multiple (adjusted for size and gross margin).
adi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £818.7k based on an EBITDA of £183.2k and a 4.47x industry multiple (adjusted for size and gross margin).
adi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £2.7m based on Net Assets of £1.3m and 2.07x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Adi Pharma Limited Overview
Adi Pharma Limited is a live company located in bedford, MK45 5BF with a Companies House number of 09897158. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in December 2015, it's largest shareholder is urvashiben kapadiya with a 100% stake. Adi Pharma Limited is a young, small sized company, Pomanda has estimated its turnover at £4.9m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Adi Pharma Limited Health Check
Pomanda's financial health check has awarded Adi Pharma Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £4.9m, make it smaller than the average company (£12.6m)
- Adi Pharma Limited
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (5.2%)
- Adi Pharma Limited
5.2% - Industry AVG
Production
with a gross margin of 30.7%, this company has a comparable cost of product (30.7%)
- Adi Pharma Limited
30.7% - Industry AVG
Profitability
an operating margin of 3.7% make it more profitable than the average company (2.9%)
- Adi Pharma Limited
2.9% - Industry AVG
Employees
with 4 employees, this is below the industry average (23)
4 - Adi Pharma Limited
23 - Industry AVG
Pay Structure
on an average salary of £49.6k, the company has an equivalent pay structure (£49.6k)
- Adi Pharma Limited
£49.6k - Industry AVG
Efficiency
resulting in sales per employee of £1.2m, this is more efficient (£429.3k)
- Adi Pharma Limited
£429.3k - Industry AVG
Debtor Days
it gets paid by customers after 79 days, this is later than average (40 days)
- Adi Pharma Limited
40 days - Industry AVG
Creditor Days
its suppliers are paid after 64 days, this is slower than average (31 days)
- Adi Pharma Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 4 days, this is less than average (71 days)
- Adi Pharma Limited
71 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 42 weeks, this is more cash available to meet short term requirements (14 weeks)
42 weeks - Adi Pharma Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 47.9%, this is a lower level of debt than the average (64.1%)
47.9% - Adi Pharma Limited
64.1% - Industry AVG
ADI PHARMA LIMITED financials
Adi Pharma Limited's latest turnover from November 2023 is estimated at £4.9 million and the company has net assets of £1.3 million. According to their latest financial statements, Adi Pharma Limited has 4 employees and maintains cash reserves of £969.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 4 | 3 | 3 | 3 | 2 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 157,033 | 155,698 | 155,808 | 729 | 911 | 1,139 | 1,423 | 279 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 157,033 | 155,698 | 155,808 | 729 | 911 | 1,139 | 1,423 | 279 |
| Stock & work in progress | 41,404 | 39,754 | 42,000 | 22,000 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,059,187 | 1,501,351 | 1,228,398 | 1,197,084 | 1,251,258 | 960,481 | 444,497 | 208,981 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 270,000 | 0 | 2,890 | 2,890 | 0 | 0 | 0 | 0 |
| Cash | 969,321 | 1,034,029 | 655,540 | 540,739 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,339,912 | 2,575,134 | 1,928,828 | 1,762,713 | 1,251,258 | 960,481 | 444,497 | 208,981 |
| total assets | 2,496,945 | 2,730,832 | 2,084,636 | 1,763,442 | 1,252,169 | 961,620 | 445,920 | 209,260 |
| Bank overdraft | 379,079 | 400,516 | 147,293 | 754 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 596,491 | 851,656 | 623,169 | 629,013 | 719,958 | 611,906 | 360,804 | 205,501 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 219,792 | 320,423 | 370,692 | 387,772 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,195,362 | 1,572,595 | 1,141,154 | 1,017,539 | 719,958 | 611,906 | 360,804 | 205,501 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 1,520 | 1,520 | 770 | 667 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 1,520 | 1,520 | 770 | 667 |
| total liabilities | 1,195,362 | 1,572,595 | 1,141,154 | 1,017,539 | 721,478 | 613,426 | 361,574 | 206,168 |
| net assets | 1,301,583 | 1,158,237 | 943,482 | 745,903 | 530,691 | 348,194 | 84,346 | 3,092 |
| total shareholders funds | 1,301,583 | 1,158,237 | 943,482 | 745,903 | 530,691 | 348,194 | 84,346 | 3,092 |
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 796 | 110 | 182 | |||||
| Amortisation | 0 | 0 | 0 | |||||
| Tax | ||||||||
| Stock | 1,650 | -2,246 | 20,000 | 22,000 | 0 | 0 | 0 | 0 |
| Debtors | -172,164 | 270,063 | 31,314 | -51,284 | 290,777 | 515,984 | 235,516 | 208,981 |
| Creditors | -255,165 | 228,487 | -5,844 | -90,945 | 108,052 | 251,102 | 155,303 | 205,501 |
| Accruals and Deferred Income | -100,631 | -50,269 | -17,080 | 386,252 | 0 | 750 | 103 | 667 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | -64,708 | 378,489 | 114,801 | 540,739 | 0 | 0 | 0 | 0 |
| overdraft | -21,437 | 253,223 | 146,539 | 754 | 0 | 0 | 0 | 0 |
| change in cash | -43,271 | 125,266 | -31,738 | 539,985 | 0 | 0 | 0 | 0 |
adi pharma limited Credit Report and Business Information
Adi Pharma Limited Competitor Analysis
Perform a competitor analysis for adi pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in MK45 area or any other competitors across 12 key performance metrics.
adi pharma limited Ownership
ADI PHARMA LIMITED group structure
Adi Pharma Limited has no subsidiary companies.
Ultimate parent company
ADI PHARMA LIMITED
09897158
adi pharma limited directors
Adi Pharma Limited currently has 1 director, Mrs Urvashiben Kapadiya serving since Dec 2015.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Urvashiben Kapadiya | England | 35 years | Dec 2015 | - | Director |
P&L
November 2023turnover
4.9m
-23%
operating profit
182.4k
0%
gross margin
30.8%
+3.07%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
1.3m
+0.12%
total assets
2.5m
-0.09%
cash
969.3k
-0.06%
net assets
Total assets minus all liabilities
adi pharma limited company details
company number
09897158
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
47910 - Retail sale via mail order houses or via Internet
incorporation date
December 2015
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
unit 4 the workshops, greenfield road, bedford, MK45 5BF
Bank
-
Legal Advisor
-
adi pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to adi pharma limited. Currently there are 3 open charges and 0 have been satisfied in the past.
adi pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
